No Detail Found!

Discovering a combination of natural compounds for treatment of chronic cancer pain based on bioinformatics

Author(s)
Weichen Si Health Management Center, Fengtai District Education Committee of Beijing Municipality,Beijing 100070,China
Abstract
Background & Objective: The incidence of malignant disease has been increasing the world over, and with it the number of patients suffering from severe cancer pain is also increasing with every passing day. We aimed to find a potentially effective combination of natural compounds for the treatment of chronic cancer pain (CCP) using bioinformatics methods, and provide a theoretical basis for subsequent laboratory experiments and clinical trials. Methodology: Six natural compounds, including bakuchiol, cinnamaldehyde, curcumin, eugenol, salicin and xanthoxylin, were selected as candidates for new drugs by consulting a large number of relevant literatures. Their targets were obtained from the Swiss Target Prediction database. The related targets of CCP were obtained from GeneCards, OMIM and DisGent databases. Cytoscape software was used to construct the "compound-targetdisease" network. Protein-protein interaction network (PPI) was constructed by STRING platform; GO function and KEGG pathway enrichment analysis were performed by R language software. Results: A total of 197 targets were obtained from the Swiss Target Prediction database; 10767 CCP of disease targets were obtained after searching and removing duplications in the disease database. Twelve core targets, AKT1, SRC, STAT3, ESR1, RELA, EP300, MAPK1, MAPK14, CCNA2, EGFR, GSK3B and PRKCZ, were identified by PPI analysis. GO functional enrichment analysis yielded 1950 entries. KEGG enrichment analysis revealed 134 pathways with statistical significance, among which pathways related to CCP were more than those related to nerve. Conclusion: The mechanism of action of these six compounds in the treatment of chronic cancer pain is multi-target and multi-pathway related. Through protein-protein interaction analysis, GO function and KEGG pathway enrichment analysis, it is found that these six compounds can be used as candidate drugs for the treatment of chronic cancer pain, which will be further studied in the future.
Publication Details
Page(s) 431-439
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 27, Issue: 5, Year: 2023

Request the full text from PASTIC

Keywords
Bioinformatics, Natural compounds, Chronic Cancer Pain, New Drug Discovery
References
Management Pain . .. 2021 Feb, 2 : 599721.
.2020 .. , : .
. .. Technologies in Health; 2020 May, 28 : .
Nurs Measurement. Semin Oncol .2019 .. , 35(3) : 229-234.
.2019 .. , 04 : .
. .. , 11(3) : 264-270.
. .where are we now? Pain Manag. 2019 Jan, 1(1) : 63-79.
. .. -0031, : .
.2019 .. Adult Cancer Pain, Version, 3 : .
Guidelines in Oncology .2019 .. J Natl Compr Canc Netw, : .
.2019 .. , 1(8) : 977-1007.
. .herbal medicines. 2014 Apr, 16 : 13.
. .. DOI: 10.1186/1758-2946-6-13, : .
. .PubChem in 2021: new data content and improved web. , : .
. .. 2021 Jan, 8(D1) : D1388.
. .. , : .
Daina A,Michielin O,Zoete V. . .SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. 2019 Jul, 2(W1) : W357-W364.
Stelzer G,Rosen N,Plaschkes I,Zimmerman S,Twik M,Fishilevich S . .The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. Curr Protoc Bioinformatics. 2016 Jun, 20(54) : 30-1.
Amberger JS,Bocchini CA,Schiettecatte F,Scott AF,Hamosh A. OMIM. .2015 .org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res, 43 : D789-98.
Piñero J,Ramírez-Anguita JM,Saüch-Pitarch J,Ronzano F,Centeno E,Sanz F . .The DisGeNET knowledge platform for disease genomics: 2019 update. 2020 Jan, 8(D1) : D845-D855.
Szklarczyk D,Gable AL,Lyon D,Junge A,Wyder S,HuertaCepas J . .STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. 2019 Jan, 8(D1) : D607-D613.
Yu G,Wang LG,Han Y,He QY . .clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS., : .
.2011 .. , 16(5) : 284-7.
.2016 .. , 05 : .
Yu G,Wang LG,Yan GR,He QY . .DOSE: an R/Bioconductor package for disease ontology semantic and enrichment analysis. Bioinformatics. 2015 Feb, 15(4) : 608-9.
Luo W .2013 .Pathview: an R/Biocondutor package for pathway-based data integration and visualization. Bioinformatics, 29(14) : 1830-1831.
Chen C,Marcus A,Li W,Hu Y,Calzada JP,Grossniklaus U . .The Arabidopsis ATK1 gene is required for spindle morphogenesis in male meiosis. Development, 129(10) : 2401-9.
Marcus AI,Ambrose JC,Blickley L,Hancock WO,Cyr RJ .2002 .Arabidopsis thaliana protein, ATK1, is a minus-end directed kinesin that exhibits non-processive movement. Cell Motil Cytoskeleton, 52(3) : 144-50.
Dockx J,Quaedvlieg N,Keultjes G,Kock P,Weisbeek P,Smeekens S. .1995 .The homeobox gene ATK1 of Arabidopsis thaliana is expressed in the shoot apex of the seedling and in flowers and inflorescence stems of mature plants. Plant Mol Biol, 28(4) : 723-37.
Hotta T,Lee YJ,Higaki T,Hashimoto T,Liu B .2022 .Two Kinesin-14A Motors Oligomerize to Drive Poleward Microtubule Convergence for Acentrosomal Spindle Morphogenesis in Arabidopsis thaliana. Front Cell Dev Biol. 2022 Jul, 22 : 949345.
Lu S,Chen L,Tang L .2019 .Upregulation of AKT1 and downregulation of AKT3 caused by dysregulation of microRNAs contributes to pathogenesis of hemangioma by promoting proliferation of endothelial cells. J Cell Physiol, 234(11) : 21342-21351.
Roskoski R .2004 .Src protein-tyrosine kinase structure and regulation. 2004 Nov, 09(4) : 1155-64.
De Kock L,Freson K. . .The (Patho)Biology of SRC Kinase in Platelets and Megakaryocytes. 2020 Nov, 56(12) : 633.
Hillmer EJ,Zhang H,Li HS,Watowich SS . .STAT3 signaling in immunity. Cytokine Growth Factor Rev, 31 : 1-15.
Zou S,Tong Q,Liu B,Huang W,Tian Y,Fu X. Targeting . .STAT3 in Cancer Immunotherapy. 2020 Sep, 24(1) : 145.
Guanizo AC,Fernando CD,Garama DJ,Gough DJ .2018 .STAT3: a multifaceted oncoprotein. Growth Factors, 36(1-2) : 1-14.
Dustin D,Gu G,Fuqua SAW . .ESR1 mutations in breast cancer. 2019 Nov, 1(21) : 3714-3728.
Brett JO,Spring LM,Bardia A,Wander SA . .ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptorpositive breast cancer. 2021 Aug, 15(1) : 85.
Nakazato A,Mochizuki M,Shibuya-Takahashi R,Fujimori H,Fujii K,Saijoh S . .RELA is required for CD271 expression and stem-like characteristics in hypopharyngeal cancer. 2022 Oct, 22(1) : 17751.
Korc M. . .RelA: a tale of a stitch in time. J Clin Invest. 2016 Aug, 1(8) : 2799-801.
Durbin AD,Wang T,Wimalasena VK,Zimmerman MW,Li D,Dharia NV . .EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma. 2022 Mar, 21(3) : 2159-8290.
Attar N,Kurdistani SK . .Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. 2017 Mar, 1(3) : a026534.
Deng R,Zhang HL,Huang JH,Cai RZ,Wang Y,Chen YH .2020 .MAPK1/3 kinase-dependent ULK1 degradation attenuates mitophagy and promotes breast cancer bone metastasis. Autophagy, 17(10) : 3011-3029.
Hirota Y,Yamashita S,Kurihara Y,Jin X,Aihara M,Saigusa T .2015 .Mitophagy is primarily due to alternative autophagy and requires the MAPK1 and MAPK14 signaling pathways. Autophagy, 11(2) : 332-43.
0

Citations

0

Downloads

41

Views